Subscribe


PD breaking news – ACCC Lipitor case dismissed

Pfizer’s market power not “substantial” at time of Lipitor offers. 

The Federal Court has dismissed the Australian Competition and Consumer Commission’s (ACCC) anti-competitive conduct case against Pfizer Australia today.

The ACCC allegations related to offers made to pharmacies in early 2012 for the supply of Lipitor and Pfizer’s generic atorvastatin product, with the organisation alleging Pfizer had a substantial degree of market power in the atorvastatin market and was proscribed from using that power to prevent competitive conduct (PD 08 Oct 14).

Justice Flick found that while Pfizer had taken advantage of its market power by engaging in the alleged conduct, this market power was no longer “substantial” at the time the offers were made in January 2012, the ACCC said.

The Justice also found the ACCC had not established that Pfizer had pursued its conduct to deter competitors from engaging in competitive conduct or for the purpose of substantially lessening competition, the organisation said.

Previously, the ACCC said it would seek in excess of $10m for each alleged contravention.

Chairman Rod Sims said the organisation would “carefully consider” the judgement.

“The ACCC brought this case because it raised important public interest issues regarding the conduct of a patent holder nearing the expiry of that patent and what constitutes permissible competitive conduct.”

See tomorrow’s Pharmacy Daily for more information.

This Pharmacy Daily breaking news brought to you by Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 25 Feb 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

21 Feb

Summer Waves After Shave - MILKMAN Grooming Co brings its newly released ...


21 Feb

Dreambaby’s new Ezy-Potty - DREAMBABY launches its new Ezy-Potty. Designed to ...


21 Feb

Daily Leave-In Conditioner - JOHN Frieda Frizz Ease Daily Nourishment Leave-In ...


21 Feb

Body Butter — Citrus Revival - OLIVE Oil Skincare Body Butter -- Citrus ...


21 Feb

Dispensary Corner 21 Feb 18 - THE people of the United Kingdom were ...


21 Feb

US top 10 drugs - US PHARMACEUTICAL industry consultant company EvaluatePharma has ...


21 Feb

Multiple cancer vax? - US SCIENTISTS say it may be possible ...


21 Feb

MHR hits 5.5 million - MY HEALTH Record Statistics published this week ...


21 Feb

New APC Pres and VP - THE Australian Pharmacy Council (APC) has elected ...


21 Feb

Deprescribing data - THE National Health and Medical Research Council ...


21 Feb

Managing GORD - GUILD Learning and Development is partnering with ...


21 Feb

Hunt urges PBAC - RESPONDING to interest from pharmaceutical companies and ...


21 Feb

AFP Adelaide ice bust - MINISTER for Rural Health Bridget McKenzie has ...


21 Feb

Organ donation >10K - FEDERAL Minister for Aged Care and Indigenous ...


21 Feb

CW nets major partnership - AUSTRALIAN pharmacy discount retail group Chemist Warehouse ...


21 Feb

EBOS H1 earnings up 15.6% - ASX-LISTED marketer, wholesaler and distributor of healthcare, ...


21 Feb

Gabapentinoid abuse up - THE US Food and Drug Administration (FDA) ...


20 Feb

Guild Update 20 Feb 18: Workplace resources - GUILD Members may be interested to know ...


20 Feb

Dispensary Corner 20 Feb 18 - SUFFERERS of conditions like irritable bowel syndrome ...


20 Feb

Meds reconciliation - HIGHER accuracy of complex medication reconciliation can ...



Show Pharmacy Daily items by month: